Status:
UNKNOWN
CAR T-CELL Therapy Educational Video Trial
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Hematologic Malignancy
CAR-T Cell Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test a new educational video to help patients and doctors talk about CAR-T cell therapy, a treatment being used in cancer. \- Educational video tool for patients recei...
Detailed Description
This research study is a Feasibility Study, which is the first-time investigators are examining this educational video tool for patients receiving CAR-T cell therapy. The research study procedures in...
Eligibility Criteria
Inclusion
- 18 years or age or older
- Established diagnosis of a hematologic malignancy
- Under consideration for CAR T-cell therapy at Massachusetts General Hospital
Exclusion
- Significant uncontrolled psychiatric disorders (psychotic disorder, bipolar disorder, major depression) or other co-morbid disease (dementia, cognitive impairment), which the primary oncologist believes prohibits informed consent or participation in the study
- Undergoing CAR T-cell therapy for solid tumor malignancy
- Inability to comprehend English, as the video is currently only available in English at this time
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 24 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04280133
Start Date
May 25 2020
End Date
February 24 2023
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115